Early Access — free while we kick the tires
EdgarHawk

PCT PureCycle Technologies, Inc. Insider Trading

2 filings analyzed · Latest 2025-02-10
Insider buys
2
Insider sells
0
Unique insiders
1
Direction
Net buying

Historically, high-priority insider buys have outperformed the S&P 500 by a median ~2% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 5,751, 2021-2026). Past results don't predict the future. How we measure this ↗

February 2025
2025-02-10
high
619,925 shares
$4,996,596
@ $8.06
Significance 6/10

10% Owner SYLEBRA CAPITAL LLC bought 619,925 shares of PCT at $8.06 for $5.0M on 2025-02-06.

SYLEBRA CAPITAL LLC, a 10% owner, purchased 619,925 shares at $8.06 on 2025-02-06, increasing holdings from 33,457,649 to 34,077,574 shares. The transaction occurs as PCT trades at $8.48, down 40.7% from its 52-week high and down 33.0% over 90 days. At this same ticker, SYLEBRA's prior buy (2024-09-13) delivered a 90-day return of +156.9%. However, the company reported a net loss of $90,639,000 for its most recent full fiscal year, and the stock has declined 12.6% in the past 30 days alone. This purchase signals continued accumulation by a substantial shareholder into a profitless company during a period of significant price weakness, but comes against a backdrop of ongoing operational losses and recent sharp downside momentum.

September 2024
2024-09-16
medium
4,264,393 shares
$20,000,003
@ $4.69
Significance 6/10

10% owner Sylebra Capital bought 4,264,393 shares of PCT at $4.69 ($20.0M) on 2024-09-13; now holds 33,050,456 shares.

Sylebra Capital, a 10% shareholder, purchased 4,264,393 shares for $20,000,003.17 at $4.69 per share, increasing its stake by 14.8% to 33,050,456 total shares. The transaction represents a substantial capital commitment from a substantial shareholder at a price well below the current $8.90 level, yet the company remains unprofitable with a net loss of $48,212,000.00 over its most recent full fiscal year. The 30-day price appreciation of +57.0% and recent price recovery to the 52-week high of $8.90 suggest significant post-transaction momentum, though this timing pattern does not align with the insider's cross-ticker track record, which shows only 1 prior buy and 1 prior sell with a 90-day well-timed sell rate of 0.00%.

Insiders here also file at

More Chemicals and Allied Products companies

Get alerts for PCT

Add PCT to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access